Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -27.27M
June 30, 2026 -48.49M
March 31, 2026 -46.21M
December 31, 2025 -46.27M
September 30, 2025 -70.08M
June 30, 2025 -37.26M
March 31, 2025 -22.70M
December 31, 2024 -4.693M
September 30, 2024 -2.141M
June 30, 2024 -15.79M
March 31, 2024 -17.07M
December 31, 2023 -16.76M
September 30, 2023 -1.49M
June 30, 2023 -0.071M
Date Value
March 31, 2023 -6.735M
December 31, 2022 -8.811M
September 30, 2022 -11.54M
June 30, 2022 -9.214M
March 31, 2022 -2.585M
December 31, 2021 -0.043M
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Absci Corp. -9.453M
Editas Medicine, Inc. 47.74M
Twist Bioscience Corp. 240.80M
Beam Therapeutics, Inc. 124.52M
AbbVie, Inc. 48.66B